chr11-122977657-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001098169.2(BSX):āc.694G>Cā(p.Val232Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000831 in 1,608,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001098169.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BSX | NM_001098169.2 | c.694G>C | p.Val232Leu | missense_variant | 3/3 | ENST00000343035.3 | |
LOC124902774 | XR_007062926.1 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BSX | ENST00000343035.3 | c.694G>C | p.Val232Leu | missense_variant | 3/3 | 5 | NM_001098169.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000473 AC: 72AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000392 AC: 95AN: 242628Hom.: 0 AF XY: 0.000377 AC XY: 50AN XY: 132466
GnomAD4 exome AF: 0.000868 AC: 1264AN: 1456436Hom.: 0 Cov.: 31 AF XY: 0.000839 AC XY: 608AN XY: 724728
GnomAD4 genome AF: 0.000473 AC: 72AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.694G>C (p.V232L) alteration is located in exon 3 (coding exon 3) of the BSX gene. This alteration results from a G to C substitution at nucleotide position 694, causing the valine (V) at amino acid position 232 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at